Checkpoint Inhibitor Pneumonitis Induced by Anti-PD-1/PD-L1 Therapy in Non-Small-Cell Lung Cancer: Occurrence and Mechanism

Immune checkpointty inhibitors (ICIs), particularly those targeting programmed death 1 (PD-1) and anti-programmed death ligand 1 (PD-L1), enhance the antitumor effect by restoring the function of the inhibited effector T cells and produce durable responses in a large variety of metastatic and late p...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Jianqiong, Wu, Yuanjun, Yang, Xue, Gan, Lu, Xue, Jianxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021596/
https://www.ncbi.nlm.nih.gov/pubmed/35464480
http://dx.doi.org/10.3389/fimmu.2022.830631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021596/
https://www.ncbi.nlm.nih.gov/pubmed/35464480
http://dx.doi.org/10.3389/fimmu.2022.830631

Ejemplares similares